Skip to main content
Premium Trial:

Request an Annual Quote

Certara Repeats Bid to Acquire Symyx

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Certara today issued a letter to Symyx's board revising its offer to acquire the company and removing any doubt that its offer provides certainty of closure.

In its letter, Certara confirms its bid of $5.75 per share in cash originally made to Symyx last week. In addition, Certara said the offer is irrevocable and effective immediately; "empowers the Symyx [board] to accept the offer and legally bind Certara once the Accelrys merger has been terminated;" is contained in a signed merger agreement; and is guaranteed by Vector Capital, Certara's private equity backer.

The revised offer "should remove any doubt in the minds of you or the Symyx stockholders that our proposal provides certainty of closure," Certara said in the letter.

Earlier this week, Symyx rejected Certara's offer, saying it did not represent a superior offer to an earlier bid by Accelerys. Symyx also said that Certara's offer does not provide "sufficient certainty to closure necessary to protect Symyx stockholders."

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.